See every side of every news story

Published 3 days ago • loading... • Updated 3 days ago

Elanco Secures Approval of Zenrelia™ (Ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs

Elanco Animal Health Incorporated announced that Zenrelia™ has received approval from the European Commission.
Zenrelia offers a once-daily tablet for managing pruritus associated with allergic dermatitis in dogs aged at least 12 months.
Elanco stated, "We're excited to bring Zenrelia to veterinarians and pet owners in Europe..."
Zenrelia is positioned as a significant addition to Elanco's pet health portfolio in Europe.

Insights by Ground AI

Does this summary seem wrong?

67 Articles

67 Articles

LoudounTimes.com

PR Newswire

Charleston Gazette-Mail

WBOC 16

TBNweekly

The Daily News

journalgazette.net

The Herald-Dispatch

Brattleboro Reformer

The Laconia Daily Sun

Madison Courier

Islander News

The Journal

Bennington Banner

The Berkshire Eagle

Mt. Airy News

Rutland Herald

Kingsport Times-News

waynecountynews.com

Suncoast News

The Coal Valley News

williamsondailynews.com

Alex City Outlook

Livingston County News

The Logan Banner

The Westerly Sun

WDEL 101.7FM

The Times-News

MyHorryNews.com

The Conway Daily Sun

Williamson Herald

parispi.net

Smith Mountain Eagle

Woonsocket Call

Hometown News Brevard

Finger Lakes Times

The Daily News - Jacksonville, NC

Hometown News Volusia

thebesttimes.com

Biltmore Beacon

keenesentinel.com

The Caswell Messenger

kentuckytoday.com

coastaltvnews.com

News of Orange

thesentinel.com

Oswego County News Now

decaturdailydemocrat.com

Essex Reporter

Prince William Times

Fairfax County Times

manchesterjournal.com

willistonobserver.com

Observer News Enterprise

herald-citizen.com

theohiopressnetwork.com

miltonindependent.com

SRI News

Florida Courier

The News Progress

daily-tribune.com

Loudoun Now

The Erwin Record

www.Arundel.News

delmarvasportsnetwork.com

The Free Press

+65 Reposted by 65 other sources

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs

The European Commission's Approval of Zenrelia reinforces safety and efficacy and further expands opportunities to treat itchy dogs around the worldLaunch to begin immediately with product in market before the end of Q3 2025

3 days ago

Read Full Article

Elanco Secures Major EU Victory: New Once-Daily Dog Dermatitis Drug Matches Market Leader in Clinical Trial

New oral treatment for itchy dogs proves equally effective as market leader in 338-dog study. Immediate EU launch planned with Q3 availability. See clinical results.

3 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources67

Leaning Left4Leaning Right8Center17Last Updated2 days agoBias Distribution

59% Center

Bias Distribution

59% of the sources are Center

59% Center

+12

+2

Untracked bias

+29

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States 3 days ago on Thursday, July 24, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.